NCT02097277 - A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes | Biotech Hunter

Enrollment

219

Participants

Timeline

Start Date

April 15, 2014

Primary Completion Date

September 22, 2015

Study Completion Date

May 17, 2016

Conditions

Diabetes Mellitus Type 2

Interventions

BIOLOGICAL

BMS-986036

BIOLOGICAL

Placebo (Matching with BMS-986036)

Trial Locations (16)

28204

Metrolina Internal Medicine, Charlotte

33024

All Medical Research, Llc, Cooper City

40509

Central Kentucky Research Associates, Inc., Lexington

45219

Sterling Research Grp, Ltd., Cincinnati

72205

Arkansas Clinical Research, Little Rock

90057

National Research Institute, Los Angeles

91978

Encompass Clinical Research, Spring Valley

92801

Anaheim Clinical Trials Llc, Anaheim

91978-1522

Encompass Clinical Research, Spring Valley

08611

Premier Research, Trenton

V6J 1S3

Manna Research Vancouver, Vancouver

L6T 0G1

Aggarwal And Associates, Brampton

J2B 7T1

Rhodin Recherche Clinique, Drummondville

H1M 1B1

Recherche Gcp Research, Montreal

G3K 2P8

Alpha-Recherche Clinique, Québec

G6P 6P6

Medexa Recherche, Victoriaville